Table 1 Characteristics of cases with BKPyV-associated pneumonia [3,4,5,6,7,8,9]
From: Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review
Case | Report Year | Age (years)/Sex | Underlying condition | Antiviral drugs | Clinical outcome | Survival (days) |
|---|---|---|---|---|---|---|
1 | 1993 | 27, M | Hemophilia type A, AIDS | N/A | Death | N/A |
2 | 1997 | 0.7, F | Osteopetrosis, CBT (4/6) | Acyclovir | Death | 23 |
3 | 2000 | 14, M | AIDS | N/A | Death | 5 |
4 | 2002 | 49, M | CLL | Acyclovir | Death | 18 |
5 | 2005 | 69, F | CLL | N/A | Death | 6 |
6 | 2012 | 39, M | ALL, PBSCT (mismatched) | Vidarabine; Cidofovir | Death | 4 |
7 | 2018 | 70, F | DLBCL, auto-PBSCT | Cidofovir | Recovery | N/A |
8 | Our Case, 2023 | 6, M | β-thalassemia, PBSCT(6/6) | Ganciclovir; Cidofovir | Death | 10 |
9 | Our Case, 2023 | 19, M | ALL, PBSCT (haplo) | Cidofovir | Death | 12 |